Corbus pharmaceuticals to present at the guggenheim smid cap biotech conference

Norwood, mass., jan. 28, 2025 (globe newswire) -- corbus pharmaceuticals holdings, inc. (nasdaq: crbp) (“corbus” or the “company”), today announced that yuval cohen, ph.d., chief executive officer of corbus, will be participating in the guggenheim smid cap biotech conference, to be held february 5-6, 2025 in new york, ny dr. cohen will participate in analyst led fireside discussion and will attend one-on-one investor meetings.
SMID Ratings Summary
SMID Quant Ranking